title: Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma.
authors.affiliation: University Eye Hospital Lübeck, Lübeck, Germany.
authors.forename: Maximilian
authors.initials: M
authors.lastname: von Buelow
authors.forename: Stefanie
authors.initials: S
authors.lastname: Pape
authors.forename: Hans
authors.initials: H
authors.lastname: Hoerauf
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005451:Fluorescein Angiography; D018324:Hemangioma, Capillary / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019572:Retinal Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D019233:Retreatment; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab